{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:31:45Z","timestamp":1760661105218,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"DOI":"10.7759\/cureus.94734","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:29:37Z","timestamp":1760635777000},"source":"Crossref","is-referenced-by-count":0,"title":["The Hidden Metabolic Threat: A Case of Fatty Acid Oxidation Disorder Masquerading as Viral Myocarditis"],"prefix":"10.7759","author":[{"given":"Hadhami","family":"Ben Turkia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-8981(97)00185-x","article-title":"Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients","volume":"69","author":"Vianey-Saban C","year":"1998","unstructured":"Vianey-Saban C, Divry P, Brivet M, Nada M, Zabot MT, Mathieu M, Roe C. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clinica Chimica Acta. 1998, 69:43-62. 10.1016\/s0009-8981(97)00185-x","journal-title":"Clinica Chimica Acta"},{"key":"ref2","article-title":"Long-chain hydroxyacyl-COA dehydrogenase deficiency\/trifunctional protein deficiency","author":"Prasun P","year":"2022","unstructured":"Prasun P, LoPiccolo MK, Ginevic I. Long-chain hydroxyacyl-COA dehydrogenase deficiency\/trifunctional protein deficiency. GeneReviews. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-01070-0","article-title":"Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders","volume":"23","author":"Marsden D","year":"2021","unstructured":"Marsden D, Bedrosian CL, Vockley J. Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders. Genet Med. 2021, 23:816-29. 10.1038\/s41436-020-01070-0","journal-title":"Genet Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae109","article-title":"Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry","volume":"45","author":"Kaski JP","year":"2024","unstructured":"Kaski JP, Norrish G, Gimeno Blanes JR, et al.. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Eur Heart J. 2024, 45:1443-54. 10.1093\/eurheartj\/ehae109","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i21.5250","article-title":"Cardiovascular impact of COVID-19 with a focus on children: a systematic review","volume":"8","author":"Rodriguez-Gonzalez M","year":"2020","unstructured":"Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: a systematic review. World J Clin Cases. 2020, 8:5250-83. 10.12998\/wjcc.v8.i21.5250","journal-title":"World J Clin Cases"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac253","article-title":"Correction to: Multisystem inflammatory syndrome in children - United States, February 2020-July 2021","volume":"75","author":"Miller AD","year":"2022","unstructured":"Miller AD, Zambrano LD, Yousaf AR, et al.. Correction to: Multisystem inflammatory syndrome in children - United States, February 2020-July 2021. Clin Infect Dis. 2022, 75:186. 10.1093\/cid\/ciac253","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001064","article-title":"SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: a scientific statement from the American Heart Association","volume":"145","author":"Jone PN","year":"2022","unstructured":"Jone PN, John A, Oster ME, et al.. SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: a scientific statement from the American Heart Association. Circulation. 2022, 145:e1037-52. 10.1161\/CIR.0000000000001064","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022854","article-title":"Genotype and cardiac outcomes in pediatric dilated cardiomyopathy","volume":"11","author":"Khan RS","year":"2022","unstructured":"Khan RS, Pahl E, Dellefave-Castillo L, et al.. Genotype and cardiac outcomes in pediatric dilated cardiomyopathy. J Am Heart Assoc. 2022, 11:e022854. 10.1161\/JAHA.121.022854","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz SE","year":"2019","unstructured":"Lipshultz SE, Law YM, Asante-Korang A, et al.. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation. 2019, 140:e9-68. 10.1161\/CIR.0000000000000682","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.577856","article-title":"Long-chain acylcarnitines and cardiac excitation-contraction coupling: links to arrhythmias","volume":"11","author":"Aitken-Buck HM","year":"2020","unstructured":"Aitken-Buck HM, Krause J, Zeller T, Jones PP, Lamberts RR. Long-chain acylcarnitines and cardiac excitation-contraction coupling: links to arrhythmias. Front Physiol. 2020, 11:577856. 10.3389\/fphys.2020.577856","journal-title":"Front Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.100905","article-title":"Presentation and outcome of congenital heart disease during Covid-19 pandemic: a review","volume":"47","author":"Soleimani A","year":"2022","unstructured":"Soleimani A, Soleimani Z. Presentation and outcome of congenital heart disease during Covid-19 pandemic: a review. Curr Probl Cardiol. 2022, 47:100905. 10.1016\/j.cpcardiol.2021.100905","journal-title":"Curr Probl Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15048","article-title":"Clinical characteristics, diagnosis and short-term outcomes of COVID-19-associated acute myocarditis in China","volume":"12","author":"Liu H","year":"2025","unstructured":"Liu H, Zhou P, Huang Y, et al.. Clinical characteristics, diagnosis and short-term outcomes of COVID-19-associated acute myocarditis in China.  ESC Heart Fail. 2025, 12:338-52. 10.1002\/ehf2.15048","journal-title":"ESC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04175-z","article-title":"Differences between genetic dilated cardiomyopathy and myocarditis in children presenting with severe cardiac dysfunction","volume":"181","author":"Gran F","year":"2022","unstructured":"Gran F, Fidalgo A, Dolader P, et al.. Differences between genetic dilated cardiomyopathy and myocarditis in children presenting with severe cardiac dysfunction. Eur J Pediatr. 2022, 181:287-94. 10.1007\/s00431-021-04175-z","journal-title":"Eur J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010813","article-title":"Treatable massive pericardial effusion and hypertrophic cardiomyopathy in an infant with a novel homozygous ACADVL mutation: A case report","volume":"97","author":"Kim YM","year":"2018","unstructured":"Kim YM, Kim G, Ko H, Yoo HW, Lee HD. Treatable massive pericardial effusion and hypertrophic cardiomyopathy in an infant with a novel homozygous ACADVL mutation: A case report. Medicine (Baltimore). 2018, 97:e10813. 10.1097\/MD.0000000000010813","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-9001-1","article-title":"Fatty acid oxidation disorders: outcome and long-term prognosis","volume":"33","author":"Wilcken B","year":"2010","unstructured":"Wilcken B. Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis. 2010, 33:501-6. 10.1007\/s10545-009-9001-1","journal-title":"J Inherit Metab Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12165","article-title":"Fatal COVID-19 infection in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a case report","volume":"56","author":"Wongkittichote P","year":"2020","unstructured":"Wongkittichote P, Watson JR, Leonard JM, Toolan ER, Dickson PI, Grange DK. Fatal COVID-19 infection in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a case report. JIMD Rep. 2020, 56:40-5. 10.1002\/jmd2.12165","journal-title":"JIMD Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0146-0005(99)80052-4","article-title":"Sudden and unexpected neonatal death: A protocol for the postmortem diagnosis of fatty acid oxidation disorders","volume":"2","author":"Rinaldo P","year":"1999","unstructured":"Rinaldo P, Yoon HR, Yu C, Raymond K, Tiozzo C, Giordano G. Sudden and unexpected neonatal death: A protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol. 1999, 2:204-10. 10.1016\/s0146-0005(99)80052-4","journal-title":"Semin Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.231","article-title":"Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement","volume":"142","author":"den Boer ME","year":"2003","unstructured":"den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003, 142:684-9. 10.1067\/mpd.2003.231","journal-title":"J Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9542-6","article-title":"Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients","volume":"36","author":"Baruteau J","year":"2013","unstructured":"Baruteau J, Sachs P, Brou\u00e9 P, Brivet M, Abdoul H, Vianey-Saban C, Ogier de Baulny H. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis. 2013, 36:795-803. 10.1007\/s10545-012-9542-6","journal-title":"J Inherit Metab Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906033402204","article-title":"A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women","volume":"340","author":"Ibdah JA","year":"1999","unstructured":"Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999, 340:1723-31. 10.1056\/NEJM199906033402204","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376632-the-hidden-metabolic-threat-a-case-of-fatty-acid-oxidation-disorder-masquerading-as-viral-myocarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:29:38Z","timestamp":1760635778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376632-the-hidden-metabolic-threat-a-case-of-fatty-acid-oxidation-disorder-masquerading-as-viral-myocarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.94734","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}